Insulin Resistance in Idiopathic Oligospermia and Azoospermia
This study is currently recruiting participants.
Verified December 2012 by The Egyptian IVF-ET Center
Sponsor:
The Egyptian IVF-ET Center
Information provided by (Responsible Party):
Ragaa Mansour, The Egyptian IVF-ET Center
ClinicalTrials.gov Identifier:
NCT01509482
First received: January 6, 2012
Last updated: December 19, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Insulin resistance in men can be the underlying major factor in reproductive abnormalities ( chronic hypospermatogenesis ) as well as metabolic abnormalities similar to polycystic ovarian syndrome ( PCOS ) in women.
| Condition | Intervention |
|---|---|
|
Insulin Resistance Oligospermia Azoospermia |
Other: blood samples Other: Blood samples |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Insulin Resistance : a New Diagnosis of the Pathogenesis of Idiopathic Oligozoospermia and Non Obstructive Azoospermia |
Resource links provided by NLM:
Genetics Home Reference related topics:
CATSPER1-related nonsyndromic male infertility
sensorineural deafness and male infertility
Y chromosome infertility
MedlinePlus related topics:
Diabetes Medicines
Drug Information available for:
Insulin human
U.S. FDA Resources
Further study details as provided by The Egyptian IVF-ET Center:
Primary Outcome Measures:
- serum insulin [ Time Frame: one month ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Fasting Glucose [ Time Frame: one month ] [ Designated as safety issue: No ]
- cholesterol [ Time Frame: one month ] [ Designated as safety issue: No ]
- high density lipoprotein ( HDL) [ Time Frame: one month ] [ Designated as safety issue: No ]
- Low density lipoprotein ( LDL ) [ Time Frame: one month ] [ Designated as safety issue: No ]
- testosterone [ Time Frame: one month ] [ Designated as safety issue: No ]
- Triglycerides [ Time Frame: One month ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 150 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
insulin resistance
unexplained oligospermia and azoospermia
|
Other: blood samples
blood samples to test for primary and secondary outcome measures
Other Name: Unexplained oligospermia and azoospermia
|
|
Fertile males
Healthy Men with proven fertility
|
Other: Blood samples
IR Cholesterol HDL LDL Fasting Glucose Triglycerides
Other Name: Hypospermatogenesis
|
Detailed Description:
During the past decade IR has been recognized as a major contributor to the pathogenesis of chronic anovulation, hyperandrogenism and metabolic abnormalities associated with PCOS . Theoretically IR in men may result in a similar reproductive abnormalities ( chronic hypospermatogenesis ) as well as other metabolic abnormalities similar to what happens in PCOS in women .
Eligibility| Ages Eligible for Study: | 25 Years to 55 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
Infertile men
Criteria
Inclusion Criteria:
- sperm count less than 10 million per milliliter
- non-obstructive azoospermia
Exclusion Criteria:
- high FSH ( > 10 mIU/ ml )
- high prolactin ( > 36 mIU/ml )
- abnormal karyotype
- AZF
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01509482
Contacts
| Contact: Ragaa Mansour, MD,PhD | 2012 212 2299 | ragaa.mansour@gmail.com |
| Contact: Ragaa Mansour, MD,PhD | 202 2525 4955 | ragaa.mansour@gmail.com |
Locations
| Egypt | |
| The Egyptian IVF-ET center | Recruiting |
| Cairo, Egypt, 11431 | |
| Contact: Ragaa Mansour ragaa.mansour@gmail.com | |
| Principal Investigator: Ragaa Mansour, MD,PhD | |
Sponsors and Collaborators
The Egyptian IVF-ET Center
Investigators
| Principal Investigator: | Ragaa Mansour, MD,PhD | The Egyptian IVF-ET Center |
More Information
No publications provided
| Responsible Party: | Ragaa Mansour, Director, the Egyptian IVF-ET center, The Egyptian IVF-ET Center |
| ClinicalTrials.gov Identifier: | NCT01509482 History of Changes |
| Other Study ID Numbers: | insulin resistance |
| Study First Received: | January 6, 2012 |
| Last Updated: | December 19, 2012 |
| Health Authority: | Egypt: Institutional Review Board |
Keywords provided by The Egyptian IVF-ET Center:
|
insulin resistance unexplained azoospermia unexplained oligospermia |
Additional relevant MeSH terms:
|
Insulin Resistance Azoospermia Oligospermia Infertility, Male Infertility Genital Diseases, Male Hyperinsulinism |
Glucose Metabolism Disorders Metabolic Diseases Insulin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on June 18, 2013